Maintain pressure on reforms to protect NHSMHRA extend swine flu adverse drug reaction portal
The MHRA have extended the swine flu adverse drug reaction (ADR) portal to include swine flu vaccines and seasonal vaccines.
In July 2009 the MHRA launched a special swine flu ADR portal for reporting suspected adverse drug reaction to oseltamivir (Tamiflu) and zanamivir (Relenza).
The MHRA now have extended use of this portal to include suspected ADRs to new swine flu vaccines and seasonal vaccines.
Reports should include;
- the patient’s age;
- a description of the suspected adverse reaction and outcome;
- any underlying risk factors.
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Share
Have your say
You must sign in to make a comment.